A share price of 89bio Inc [ETNB] is currently trading at $8.18, down -2.04%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ETNB shares have lost -1.56% over the last week, with a monthly amount drifted -26.83%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
89bio Inc [NASDAQ: ETNB] stock has seen the most recent analyst activity on March 13, 2025, when Citigroup initiated its Buy rating and assigned the stock a price target of $25. RBC Capital Mkts downgraded its rating to a Sector Perform and decreased its price target to $15 on January 12, 2024. Oppenheimer downgraded its rating to a Perform. UBS started tracking with a Buy rating for this stock on August 28, 2023, and assigned it a price target of $36. In a note dated June 13, 2023, Evercore ISI initiated an Outperform rating and provided a target price of $49 on this stock.
89bio Inc experienced fluctuations in its stock price throughout the past year between $5.99 and $13.71. Currently, Wall Street analysts expect the stock to reach $22 within the next 12 months. 89bio Inc [NASDAQ: ETNB] shares were valued at $8.18 at the most recent close of the market. An investor can expect a potential return of 168.95% based on the average ETNB price forecast.
Analyzing the ETNB fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.77, Equity is -0.81 and Total Capital is -0.87. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.88 points at the first support level, and at 7.59 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.61, and for the 2nd resistance point, it is at 9.04.
Ratios To Look Out For
To put it in perspective, the Current Ratio for 89bio Inc [NASDAQ:ETNB] is 13.19. In addition, the Quick Ratio stands at 13.19 and the Cash Ratio stands at 3.49.
Transactions by insiders
Recent insider trading involved RA CAPITAL MANAGEMENT, L.P., Director, that happened on Jan 30 ’25 when 5.71 million shares were purchased. Director, McWherter Charles completed a deal on Jan 22 ’25 to buy 10000.0 shares. Meanwhile, Director McWherter Charles bought 5000.0 shares on Jan 21 ’25.
